ERI Control of Gene Expression Lab
Director of ERI Molecular Biology Core
Director, Pediatric Retinal Research Lab (PRRL):
Orphan pediatric retinal disease DNA sequencing, Live Ocular Imaging & ERG Services (animal).
Director Summer Undergraduate Program in Eye Research (S.U.P.E.R.)
Past President: OU chapter of the American Association of University Professors.
Current Projects:
1) Noregen(TM): protein-based therapeutic for repair of the retina vasculature. (NEI/NIH STTR Phase-1 & SBIR Phase-2 Small Business Technology Transfer, with Caeregen Therapeutics. Dr. Mitton is not an employee nor financial investor.)
2) NGS Targeted sequencing of orphan pediatric retinal diseases (Carls Foundation, Pediatric Retinal Research Foundation.)
3) Longitudinal effects of VEGFA isoforms on the retinal vasculature in vivo and intracellular signaling in human retinal endothelial cells. NIH/NEI.